Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(10):740; doi:10.1093/jnci/93.10.740
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fintor, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fintor, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 10, 740, May 16, 2001
© 2001 Oxford University Press

NEWS

Canada’s Marijuana Regulations Raise Efficacy, Safety Issues

Lou Fintor

Canada’s road toward government-sanctioned and expanded medical marijuana access is paved with good intentions but obstructed by everything from faulty science to potentially lethal consequences for patients, according to many in that country’s health care community.

Government officials proposed regulations on April 6 that expand patient access to marijuana for those who are unable to find relief from pain, nausea, loss of appetite, and other serious symptoms using conventional therapies and who have physician approval (see sidebar, next page).

But Canadian cancer experts along with other health professionals and patient advocates question marijuana’s therapeutic safety and efficacy when used with conventional . . . [Full Text of this Article]

Clinicians Skeptical

Exploiting Pain

Unrealistic Expectations

U.S. Battle Lines Drawn


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?